Article
Unique features of a recombinant haemagglutinin influenza vaccine that influence vaccine performance
2 Dec 2021
Abstract excerpt
The influenza vaccine field has been constantly evolving to improve the speed, scalability, and flexibility of manufacturing, and to improve the breadth and longevity of the protective immune response across age groups, giving rise to an array of next generation vaccines in development. Among these, the recombinant influenza vaccine tetravalent (RIV4), using a baculovirus expression vector system to express...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
